5058 POSTER Randomized Phase II Multicenter Trial of Oral Antiangiogenic Agent TSU-68 in Combination With Docetaxel Versus Docetaxel Alone in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline

✍ Scribed by Kim, S.; Ahn, J.H.; Ro, J.; Im, S.A.; Im, Y.H.; Kim, J.H.; Song, H.S.; Kang, S.Y.; Park, H.S.; Chung, H.C.

• Book ID: 122001071
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 42 KB
• Volume: 47
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(11)71500-3